In a recent literature review, Azoulay and Horowitz stated that there was no difference between BDNF levels in patient samples and healthy individuals for other hematological diseases such as mastocytosis, T-cell lymphoma, and myeloproliferative disorders [33]. This evidence concerns the gene BDNF and myeloproliferative disorder.